Gain Therapeutics Inc. (GANX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 26
-0.07
-5.2632%
$
69.95M Market Cap
- P/E Ratio
- Div Yield
464,400 Volume
-1.19 Eps
$ 1.33
Previous Close 
Want to track GANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gain Therapeutics Inc. (GANX) Statistics
Valuation metrics
Market Cap 69.95M
Enterprise value 41.27M
Trailing P/E (ttm) -2.52
Forward P/E -
PEG ratio -0.09
Price/Sales (ttm) -
Price/Book (mrq) 4.78
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 498.5K
Average volume (90 days) 460.12K
Price summary
52-Week low 1.24
52-Week high 4.34
Beta -
50-Day moving average 1.7
200-Day moving average 1.81
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.3%
Return on equity -1.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.47
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 4.36%
Book value per share (mrq) 0.26
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
